SK Biopharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,013,855	8,700,602	7,862,650	5,646,385	7,612,048	13,234,939
Market Cap Growth	-1.62%	10.66%	39.25%	-25.82%	-42.48%	-
Enterprise Value	8,823,720	8,637,734	7,807,605	5,442,304	7,267,516	12,840,764
Last Close Price	115100.00	111100.00	100400.00	72100.00	97200.00	169000.00
PE Ratio	28.13	36.14	-	-	117.39	-
Forward PE	36.43	73.81	-	-	-	-
PS Ratio	13.35	15.89	22.16	22.94	18.18	509.06
PB Ratio	13.07	15.16	24.50	17.84	17.14	34.92
P/TBV Ratio	13.55	16.24	29.59	18.86	17.90	36.83
P/FCF Ratio	63.01	93.05	-	-	-	-
P/OCF Ratio	61.66	91.68	-	-	-	-
EV/Sales Ratio	13.06	15.77	22.00	22.11	17.36	493.89
EV/EBITDA Ratio	50.27	75.93	-	-	68.18	-
EV/EBIT Ratio	55.82	89.66	-	-	76.53	-
EV/FCF Ratio	61.68	92.38	-	-	-	-
Debt / Equity Ratio	0.07	0.32	0.56	0.49	0.04	0.05
Debt / EBITDA Ratio	0.23	1.62	-	-	0.15	-
Debt / FCF Ratio	0.35	1.97	-	-	-	-
Asset Turnover	0.75	0.62	0.51	0.38	0.73	0.08
Inventory Turnover	0.31	0.40	0.35	0.53	0.60	0.13
Quick Ratio	1.84	1.26	1.47	2.28	2.64	5.67
Current Ratio	2.43	1.64	2.02	2.99	3.18	6.16
Return on Equity (ROE)	58.15%	50.72%	-11.10%	-36.66%	15.75%	-135.18%
Return on Assets (ROA)	13.73%	6.84%	-3.38%	-12.53%	10.38%	-46.83%
Return on Invested Capital (ROIC)	41.79%	27.85%	-17.66%	-89.60%	127.86%	-2063.82%
Return on Capital Employed (ROCE)	25.90%	15.00%	-7.80%	-26.20%	19.20%	-55.70%
Earnings Yield	3.56%	2.77%	-0.42%	-2.47%	0.85%	-1.87%
FCF Yield	1.59%	1.07%	-1.23%	-2.92%	-1.28%	-1.68%
Buyback Yield / Dilution	-	-	-	-	-9.12%	-10.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.